Rise In Incidence Of Cancer And Tumor Is Uplifting The Growth Of The Anastrozole Tablets Market

Anastrozole Tablets Market

 The growing prevalence of breast cancers around the globe is a prime factor propelling the growth of the anastrozole tablets market. According to the World Cancer Research Fund (WCRF) report of 2018, breast cancer is the most commonly occurring cancer in women and the second most common cancer globally. There were over 2 million new cases in 2018, globally. Furthermore, according to the World Health Organization (WHO) report of 2018, it is estimated that 627,000 women died from breast cancer in 2018, worldwide.

On the other hand, frequent drug recalls are expected to hinder the growth of the anastrozole tablets market. For example, in May 2019, Zydus Pharmaceuticals USA Inc. announced that it voluntarily recalled multiple lots of anastrozole tablets (1mg) at the retail level. The product is under investigation by the U.S. FDA. The reason for drug recall was cross-contamination due to a GMP cleaning procedure failure in the fluid bed dry processor area during the manufacturing time.

The Asia Pacific is expected to dominate the global market and this is attributed to the new product launch in order to cater to growing demand in the region. For instance, in September 2019, Cooper Pharma, a pharmaceutical manufacturing company specialized in generics/hormonal medications, announced that one of its wholly owned hormone product ANAZBOL was launched in New Delhi, India

Major players engaged in the anastrozole tablets market include Zydus Pharmaceuticals, Teva Pharmaceutical Industries Ltd., AstraZeneca Plc,Hikma Pharmaceuticals, Fresenius Kabi, Accord Healthcare Ltd., Mylan N.V., Cipla Ltd., Apotex Inc., Natco Pharma, Zhejiang Hisun, Chongqing Huapont Pharmaceutical Co., Ltd., Zhejiang Wansheng Pharmaceutical Co. Ltd., and Yangtze River Pharmaceutical Group.

The use of Anastrozole Tablets is effective in reducing the size of abnormal growths and tumors. There are various positive effects reported by users, including the reduction of breast size and firmness, reduction of symptoms associated with gynecomastia (decrease of male breasts), reduction of liver enzyme levels, and other side effects caused by drugs. The drug has also been reported to reduce the size of ovarian cysts, and it appears to help prevent the formation of endometrial tissues that contribute to fibroids. Anastrozole Tablets are available without a prescription in most countries, although one must still see their doctor before taking them as certain types of cancers and conditions may not be compatible with this treatment. Anastrozole Tablets is available from generic suppliers and through medical specialist outlets such as pharmacies and other health food shops.

Comments

Popular posts from this blog

Growing The Production And Sales Of Racing Cars And High-Performance Vehicles To Boost The Automotive Roller Tappets Market

Dextrin Is A Food Product That Has Properties Identical To Both Glucose And Maltodextrin

Oligonucleotide Synthesis Market Is Witnessing Robust Growth With Agilent Technologies Announcing To Invest Us$ 150 Million To Double Its Production Capacity For Oligonucleotides In Colorado, U.S.